- Germany's Federal Institute for Drugs and Medical Devices (BfArM) has issued a warning against the growing "vitamin drip" trend, which involves high-dose infusions of vitamins, trace elements, or amino acids marketed for wellness.
- According to Medscape, while these infusions are crucial for medical indications, there is little robust evidence supporting their use in healthy individuals.
- The BfArM highlights various health risks associated with these infusions, including hypervitaminosis due to overdosing, fluid overload, electrolyte imbalances, and allergic reactions up to anaphylactic shock.
- As reported by PTA IN LOVE, these "drip spa" and "longevity infusions" are not approved as medicinal products in Germany, meaning their efficacy, quality, and safety are not officially proven.
- Vulnerable patient groups, such as older adults and those with heart, kidney, or metabolic diseases, are particularly at risk from these treatments, as noted by Medscape.
- The trend is heavily promoted on social media platforms like Instagram and TikTok, with marketing focusing on claims of increased energy, improved skin, and a stronger immune system, often offered in beauty clinics or wellness studios.
Germany Warns on 'Vitamin Drip' Trend
Summarized by Catamist’s AI from other outlets’ reporting and checked for neutrality. Original sources are linked below.
Germany's health authorities are warning against the popular "vitamin drip" trend, which involves high-dose infusions marketed for wellness despite little scientific evidence supporting their use in healthy individuals. These unapproved "longevity infusions" carry significant health risks, including hypervitaminosis and allergic reactions, especially for vulnerable groups, and are heavily promoted on social media with unsubstantiated claims.
How this was made: Catamist’s AI summarized this story from reporting by other outlets and checked it for neutral, plain-language framing. It is a news summary, not original reporting — the original sources are linked above.
Report an issue with this article
Please sign in to report issues with this article.